Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Did you know?
What made us buy IEX@193, Tata Power@56, Titan@330, Divis@629, Persistent@700.

USFDA concludes audit at Jeevan Scientific Technology’s Bioanalytical facility in Hyderabad

24 Jan 2020

United States Food and Drug Administration (USFDA) has concluded audit at Jeevan Scientific Technology’s Bioanalytical facility in Hyderabad. The purpose of this audit was to review the BA/BE studies conducted at facilities. The auditors started the review on January 20, 2020 and completed on January 24, 2020.

The audit concluded with ‘No Observations’. This audit is specifically to access and approve the Bioequivalence studies conducted by the company for Pharmaceutical companies across the globe.

Jeevan Scientific Technology provides a range of clinical research services for healthcare/pharmaceutical industries in India and internationally. Its clinical research services comprise bio-analytical, clinical data management, biostatistics and statistical programming, medical writing, pharmacovigilance, regulatory affairs, quality assurance, and project management services, as well as clinical operation and scientific writing services.

Related Jeevan Scientific Technology Ltd. Links:

Jeevan Scientific Share Price

137.50 1.70 (1.25%) Dec 06, 18:02
1 Year Price Chart
Peers
Company Name CMP
TCS 3534.35
Infosys 1693.65
HCL Tech. 1136.60
Wipro 624.30
Tech Mahindra 1552.05
View more..
Sensex vs Jeevan Scientific
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback